Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Smiths Medical issues tracheostomy tube voluntary recall

Smiths Medical has initiated a nationwide voluntary recall of Bivona Neonatal, Pediatric and FlexTend Tracheostomy Tubes with an integrated connector that is not designed to be used with a disconnect wedge.

Study: fMRI shows disparate effects of marijuana

Different ingredients in marijuana appear to affect regions of the brain differently during brain processing functions involving responses to certain visual stimuli and tasks, according to a study published in the January issue of Archives of General Psychiatry.

FDA issues draft guidance for staff on premarket 510(k) process

The FDA has issued draft guidance to clarify current review practices of premarket notification 510(k) submissions for FDA staff and manufacturers of medical devices.

GE settles cardiac radiopharma suit for $30M

GE Healthcare has paid the U.S. $30 million, plus interest, to settle allegations that a company it acquired in 2004, Amersham Health, had violated the False Claims Act by causing Medicare to overpay for Myoview, a radiopharmaceutical used in certain cardiac diagnostic imaging procedures, according to the U.S. Department of Justice.

Janssen submits rivaroxaban to FDA for ACS treatment

Janssen Research & Development, a Johnson & Johnson company, has submitted a supplemental new drug application to the FDA seeking approval for the use of rivaroxaban (Xarelto), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS).

2011: CVB's editor picks top stories

Two oh one two. Among many rituals, practicing the change in date is a common exercise after we enter the New Year. At Cardiovascular Business, we have been looking forward to 2012 and beyond in many magazine and web articles. The selection in our final newsletter for 2011 features editor favorites, many of which provided a glimpse into the medical, regulatory and economic climate in the near future.

House rejects two-month payroll tax cut extension, including doc fix

The U.S. House of Representatives, in a vote of 229-193, rejected the bipartisan Senate bill H.R. 3630, which included a two-month extension to the payroll tax cut and a fix to the sustainable growth rate. Instead, the House Republicans are insisting on a year-long extension of the tax cut.

JAMIA: Medication management IT research falls short

A review of published literature on randomized controlled trials (RCT) investigating the effectiveness of medication management IT revealed many gaps and inconsistencies.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.